Analytical Data
-
Gene name
STARD7
- Application
-
Alternative Names
Gestational trophoblastic tumor protein 1START domain-containing protein 7 ;StARD7
-
Species
Human
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NQZ5
-
Expression Region
61-307aa
-
Molecular Weight
56.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
STARD7, a member of the StAR-related lipid transfer (START) domain protein family, plays a crucial role in cellular lipid metabolism and is implicated in various physiological processes. It is primarily involved in the transport of sterols and other lipids, influencing membrane composition and lipid signaling pathways. Research on STARD7 has gained momentum due to its potential implications in health and disease, particularly in cancer biology, where altered lipid metabolism is a hallmark of tumor progression. Furthermore, STARD7 has been linked to metabolic disorders and cardiovascular diseases, highlighting its significance in human health. Understanding the structure and function of STARD7, particularly through recombinant protein studies, enables researchers to elucidate its mechanisms and interactions at a molecular level. Utilizing recombinant DNA technology to express STARD7 in various systems facilitates the study of its biochemical properties, functional roles, and interactions with other biomolecules. This research holds promise for identifying novel therapeutic targets and developing strategies for modulating STARD7 activity in disease contexts. The exploration of STARD7 not only enhances our understanding of lipid transport processes but also contributes to the broader field of lipidomics, which investigates the complex roles of lipids in biology and disease.
